View ValuationEnsign Group 将来の成長Future 基準チェック /36Ensign Group利益と収益がそれぞれ年間12.8%と10.2%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に17.4% 11.1%なると予測されています。主要情報12.8%収益成長率11.06%EPS成長率Healthcare 収益成長20.5%収益成長率10.2%将来の株主資本利益率17.37%アナリストカバレッジLow最終更新日30 Jul 2026今後の成長に関する最新情報お知らせ • Jul 27The Ensign Group, Inc. Raises Earnings Guidance for the Year 2026The Ensign Group, Inc. raised earnings guidance for the year 2026. Due to the strength of the second quarter, the company is increasing its annual 2026 earnings guidance to $7.75 to $7.85 per diluted share, up from the previously increased guidance of $7.48 to $7.62. The company is also increasing annual revenue guidance to $5.87 billion to $5.92 billion, up from $5.81 billion to $5.86 billion. The midpoint of the earnings guidance represents an 18.7% increase over 2025 and 41.8% over 2024.お知らせ • Feb 05The Ensign Group, Inc. Provides Earnings Guidance for the Year 2026The Ensign Group, Inc. provided earnings guidance for the year 2026. For the period, the company expects annual 2026 earnings guidance of $7.41 to $7.61 per diluted share and annual revenue guidance of $5.77 billion to $5.84 billion. The midpoint of this 2026 earnings guidance represents an increase of 14.3% over 2025 results and is 36.5% higher than 2024 results.お知らせ • Nov 04The Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company expects earnings guidance to between $6.48 to $6.54 per diluted share, up from $6.34 to $6.46 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 18.4% over 2024 results and is 36.5% higher than 2023 results. The company also increasing annual revenue guidance to $5.05 billion to $5.07 billion, up from $4.99 billion to $5.02 billion, to account for current quarter growth and acquisitions have closed and anticipate closing through the remainder of the year.お知らせ • Jul 25the Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company is raising annual 2025 earnings guidance to between $6.34 to $6.46 per diluted share, up from previously raised guidance of $6.22 to $6.38 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of more than 16% over 2024 results and is 34% higher than 2023 results. The company is also increasing annual revenue guidance to $4.99 billion to $5.02 billion, up from $4.89 billion to $4.94 billion, to account for current quarter performance and acquisitions company anticipate closing through the third quarter.お知らせ • Apr 30+ 1 more updateThe Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company now expected earnings guidance to between $6.22 to $6.38 per diluted share, up from $6.16 to $6.34 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 14.5% over their 2024 results and is 32.1% higher than their 2023 results. The company also increased annual revenue guidance to $4.89 billion to $4.94 billion, up from $4.83 billion to $4.91 billion, to account for current quarter growth and acquisitions and anticipate closing during the first half of 2025.すべての更新を表示Recent updatesお知らせ • Jul 28The Ensign Group, Inc. to Report Q2, 2026 Results on Jul 28, 2026The Ensign Group, Inc. announced that they will report Q2, 2026 results on Jul 28, 2026Reported Earnings • Jul 27Second quarter 2026 earnings released: EPS: US$1.72 (vs US$1.48 in 2Q 2025)Second quarter 2026 results: EPS: US$1.72 (up from US$1.48 in 2Q 2025). Revenue: US$1.44b (up 17% from 2Q 2025). Net income: US$99.7m (up 18% from 2Q 2025). Profit margin: 6.9% (in line with 2Q 2025). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Healthcare industry in Europe.お知らせ • Jul 27The Ensign Group, Inc. Raises Earnings Guidance for the Year 2026The Ensign Group, Inc. raised earnings guidance for the year 2026. Due to the strength of the second quarter, the company is increasing its annual 2026 earnings guidance to $7.75 to $7.85 per diluted share, up from the previously increased guidance of $7.48 to $7.62. The company is also increasing annual revenue guidance to $5.87 billion to $5.92 billion, up from $5.81 billion to $5.86 billion. The midpoint of the earnings guidance represents an 18.7% increase over 2025 and 41.8% over 2024.お知らせ • Jun 29+ 7 more updatesThe Ensign Group, Inc.(NasdaqGS:ENSG) dropped from Russell Small Cap Comp Growth BenchmarkThe Ensign Group, Inc.(NasdaqGS:ENSG) dropped from Russell Small Cap Comp Growth BenchmarkDeclared Dividend • Jun 24Dividend of US$0.065 announcedShareholders will receive a dividend of US$0.065. Ex-date: 29th June 2026 Payment date: 31st July 2026 Dividend yield will be 0.1%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 4%. Cash payout ratio: 4%.お知らせ • Jun 20The Ensign Group, Inc. Declares Quarterly Dividend, Payable on or Before July 31, 2026The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before July 31, 2026, to shareholders of record as of June 30, 2026.New Risk • Jun 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Jun 10The Ensign Group, Inc. (NasdaqGS:ENSG) announces an Equity Buyback for $40 million worth of its shares.The Ensign Group, Inc. (NasdaqGS:ENSG) announces a share repurchase program. Under the program, the company will repurchase $40 million worth of common stock.お知らせ • Apr 28The Ensign Group, Inc. to Report Q1, 2026 Results on Apr 30, 2026The Ensign Group, Inc. announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Apr 04The Ensign Group, Inc., Annual General Meeting, May 13, 2026The Ensign Group, Inc., Annual General Meeting, May 13, 2026. Location: ensign services, inc, service center 29222 rancho, suite 127, san juan capistrano, california 92675., United Statesお知らせ • Feb 05The Ensign Group, Inc. Provides Earnings Guidance for the Year 2026The Ensign Group, Inc. provided earnings guidance for the year 2026. For the period, the company expects annual 2026 earnings guidance of $7.41 to $7.61 per diluted share and annual revenue guidance of $5.77 billion to $5.84 billion. The midpoint of this 2026 earnings guidance represents an increase of 14.3% over 2025 results and is 36.5% higher than 2024 results.お知らせ • Feb 03The Ensign Group, Inc. to Report Q4, 2025 Results on Feb 04, 2026The Ensign Group, Inc. announced that they will report Q4, 2025 results on Feb 04, 2026お知らせ • Dec 19The Ensign Group, Inc. Increases Quarterly Cash Dividend, Payable on or Before January 31, 2026The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before January 31, 2026, to shareholders of record as of December 31, 2025.お知らせ • Nov 04The Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company expects earnings guidance to between $6.48 to $6.54 per diluted share, up from $6.34 to $6.46 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 18.4% over 2024 results and is 36.5% higher than 2023 results. The company also increasing annual revenue guidance to $5.05 billion to $5.07 billion, up from $4.99 billion to $5.02 billion, to account for current quarter growth and acquisitions have closed and anticipate closing through the remainder of the year.お知らせ • Oct 21The Ensign Group, Inc. to Report Q3, 2025 Results on Nov 03, 2025The Ensign Group, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2025お知らせ • Sep 19The Ensign Group, Inc. Declares A Quarterly Cash Dividend , Payable on or Before October 31, 2025The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0625 per share of Ensign common stock, payable on or before October 31, 2025, to shareholders of record as of September 30, 2025.お知らせ • Sep 03Ensign Pays over $47 Million to Settle Claims in Whistleblower Suit Alleging Fraud and KickbacksWhistleblower Law Collaborative LLC, Hirst Law Group, P.C., and Bird, Marella, Rhow, Lincenberg, Drooks, & Nessim, LLP announced a settlement of over $47.3 million in a whistleblower case against The Ensign Group, Inc., and Ensign Services, Inc. ("Ensign"). The settled claims, brought in a lawsuit filed by a whistleblower in 2015, resolve allegations that Ensign knowingly engaged in fraud perpetrated against Medicare, Medicaid, and other government health care programs. The complaint, filed as a qui tam suit under the federal and California False Claims Acts (FCAs), alleged that nationwide Ensign knowingly paid kickbacks to physicians for referrals of patients to Ensign's skilled nursing facilities (SNFs) in violations of the FCAs, the federal and California Anti-Kickback Statutes, and the federal Stark self-referral law. The complaint also alleged that Ensign violated a previous Corporate Integrity Agreement (CIA) that Ensign signed with the Department of Health and Human Services (HHS) in 2013 as part of an earlier False Claims Act case settled by the company. The whistleblower worked as a former Contracts Manager at Ensign. In that role, she was responsible for reviewing, tracking, and monitoring contracts entered into by Ensign's Facilities. She also served on the Company's Compliance Committee where one of her responsibilities was to ensure that payment provisions in Ensign's contracts were in accordance with the law. The whistleblower alleged that she complained about the fraud she observed but could not get Ensign to change its conduct. As the second amended complaint alleged, as part of her work, the whistleblower observed, among other fraud, that: Ensign made inflated monthly payments to physicians to serve as medical directors and in other "consulting" capacities, when those excessive payments were designed to induce the doctors to refer patients to the Ensign's SNFs; Ensign SNF administrators admitted that while they used to pay for patient referrals with "donuts," they were now paying for referrals with "dollars"; Another Ensign administrator admitted that he performed a return on investment calculation to determine the number of referrals needed from each doctor to break even on the monthly payments made to those doctors -- and that he would raise or lower the payments to the doctors based on their number of referrals; and Ensign paid thousands of dollars each month for multiple medical directors and consultants. At one SNF alone, Ensign paid four doctors to serve as "medical directors" and paid at least ten additional doctors for "consulting agreements."The whistleblower alleged that she attempted to stop the fraud by changing the contracts to institute hourly rates tied to actual work and fair market value, rather than excessive monthly lump sum payments to induce referrals, but her attempts were overridden by Ensign. Whistleblower Law Collaborative and Hirst Law Group filed the FCAqui tam suit on behalf of the whistleblower, who alleged that Ensign had both engaged in fraud and failed to disclose its illegal conduct to the government as required. When the government allowed the whistleblower to proceed with the FCA suit in 2020, Whistleblower Law Collaborative and Hirst Law Group went forward with the case with Bird Marella as taint counsel. The team proceeded to successfully litigate the case for four years and were in the midst of discovery when the settlement was reached.お知らせ • Jul 25the Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company is raising annual 2025 earnings guidance to between $6.34 to $6.46 per diluted share, up from previously raised guidance of $6.22 to $6.38 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of more than 16% over 2024 results and is 34% higher than 2023 results. The company is also increasing annual revenue guidance to $4.99 billion to $5.02 billion, up from $4.89 billion to $4.94 billion, to account for current quarter performance and acquisitions company anticipate closing through the third quarter.お知らせ • Jul 22The Ensign Group, Inc. to Report Q2, 2025 Results on Jul 24, 2025The Ensign Group, Inc. announced that they will report Q2, 2025 results on Jul 24, 2025お知らせ • Jun 21The Ensign Group, Inc. Announces Board Changes, Effective September 1, 2025The Ensign Group, Inc. announced that Christopher Christensen, Executive Chairman and member of the Ensign Board of Directors, has provided notice to the board of his intent to retire from both his roles effective September 1, 2025. Barry R. Port, Ensign’s Chief Executive Officer, has been appointed to serve as Chair of the Board of Directors, effective September 1, 2025. Mr. Port will continue to serve as Ensign’s Chief Executive Officer, a role he’s held since May 30, 2019. Prior to that, he served as Chief Operating Officer for Ensign Services, Inc. for five years and has been with the organization in various operational roles for over 21 years. Mr. Port has served as Chief Executive Officer since May 2019 and is a currently a member of the board. Before becoming CEO, Mr. Port served as Chief Operating Officer at Ensign Services, Inc. from January 2012 to May 2019, overseeing field support and back-office services for affiliated skilled nursing and senior living operations nationwide. Prior to that, he was President of Keystone Care, Inc. from March 2006 to December 2011, where he provided operational oversight for facilities across Texas. Earlier in his career, he held various roles operating affiliated skilled nursing campuses in Arizona and Texas. In addition, Marivic Uychiat has been appointed to serve as a member of the Board of Directors, filling the vacancy on the board created by Mr. Christensen’s retirement, effective September 1, 2025. Ms. Uychiat has been a key contributor in the organization for over 22 years and has served as Executive Vice President of Clinical Services at Ensign Services, Inc. since 2016. Before assuming her current role, Ms. Uychiat served as Director of Clinical Services for the company’s California operations. Her extensive background also includes a decade-long tenure as Director of Nursing at Vista Knoll Specialized Care, where she oversaw comprehensive care for psychiatric/neuro-behavioral, dementia, and short-term post-acute rehabilitation patients. Ms. Uychiat holds a Bachelor's Degree in nursing, graduating Cum Laude from the University of St. La Salle. She also completed the Chief Nursing Officer program at University of California Irvine Paul Merage School of Business. She brings nearly three decades of leadership in the Skilled Nursing and Post-Acute Care industry to the board.Her professional expertise spans skilled healthcare management, clinical program development, and policymaking.お知らせ • Jun 20the Ensign Group, Inc. Declares Quarterly Dividend, Payable on or Before July 31, 2025The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0625 per share of Ensign common stock, payable on or before July 31, 2025, to shareholders of record as of June 30, 2025.お知らせ • Jun 03The Ensign Group, Inc. (NasdaqGS:ENSG) acquired operations of Ironwood Rehabilitation and Care Center.The Ensign Group, Inc. (NasdaqGS:ENSG) acquired operations of Ironwood Rehabilitation and Care Center on June 1, 2025. The Ensign Group, Inc. (NasdaqGS:ENSG) completed the acquisition of operations of Ironwood Rehabilitation and Care Center on June 1, 2025.お知らせ • Apr 30+ 1 more updateThe Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company now expected earnings guidance to between $6.22 to $6.38 per diluted share, up from $6.16 to $6.34 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 14.5% over their 2024 results and is 32.1% higher than their 2023 results. The company also increased annual revenue guidance to $4.89 billion to $4.94 billion, up from $4.83 billion to $4.91 billion, to account for current quarter growth and acquisitions and anticipate closing during the first half of 2025.業績と収益の成長予測BIT:1ENSG - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20287,096527434N/A312/31/20276,505475390N/A512/31/20265,905421385N/A56/30/20265,487379419608N/A3/31/20265,274363406592N/A12/31/20255,058344371564N/A9/30/20254,829328290481N/A6/30/20254,615323277463N/A3/31/20254,423309212384N/A12/31/20244,260298189347N/A9/30/20244,109240247332N/A6/30/20243,968225202321N/A3/31/20243,853218255364N/A12/31/20233,729209270377N/A9/30/20233,559248164342N/A6/30/20233,388240141311N/A3/31/20233,199234109275N/A12/31/20223,025225185273N/A9/30/20222,90921356294N/A6/30/20222,808204114297N/A3/31/20222,714196102287N/A12/31/20212,627195108276N/A9/30/20212,563192226296N/A6/30/20212,494188234308N/A3/31/20212,440179320381N/A12/31/20202,403170298373N/A9/30/20202,334152193342N/A6/30/20202,247131120299N/A3/31/20202,155111N/A200N/A12/31/20192,03792N/A192N/A9/30/20191,72858N/A185N/A6/30/20191,73056N/A176N/A3/31/20191,73458N/A190N/A12/31/20181,75559N/A210N/A9/30/20181,99177N/A167N/A6/30/20181,94871N/A149N/A3/31/20181,90061N/A94N/A12/31/20171,59817N/A80N/A9/30/20171,79548N/A66N/A6/30/20171,75145N/A62N/A3/31/20171,71344N/A81N/A12/31/20161,65550N/A74N/A9/30/20161,59545N/A91N/A6/30/20161,51848N/A63N/A3/31/20161,41949N/A40N/A12/31/20151,34255N/A33N/A9/30/20151,24653N/A31N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 1ENSGの予測収益成長率 (年間12.8% ) は 貯蓄率 ( 3.4% ) を上回っています。収益対市場: 1ENSGの収益 ( 12.8% ) はItalian市場 ( 10.2% ) よりも速いペースで成長すると予測されています。高成長収益: 1ENSGの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 1ENSGの収益 ( 10.2% ) Italian市場 ( 5.7% ) よりも速いペースで成長すると予測されています。高い収益成長: 1ENSGの収益 ( 10.2% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 1ENSGの 自己資本利益率 は、3年後には低くなると予測されています ( 17.4 %)。成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/23 19:22終値2026/08/21 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋The Ensign Group, Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Tao QiuBerenbergJoseph FranceCantor Fitzgerald & Co.Peter MartinCitizens JMP Securities, LLC10 その他のアナリストを表示
お知らせ • Jul 27The Ensign Group, Inc. Raises Earnings Guidance for the Year 2026The Ensign Group, Inc. raised earnings guidance for the year 2026. Due to the strength of the second quarter, the company is increasing its annual 2026 earnings guidance to $7.75 to $7.85 per diluted share, up from the previously increased guidance of $7.48 to $7.62. The company is also increasing annual revenue guidance to $5.87 billion to $5.92 billion, up from $5.81 billion to $5.86 billion. The midpoint of the earnings guidance represents an 18.7% increase over 2025 and 41.8% over 2024.
お知らせ • Feb 05The Ensign Group, Inc. Provides Earnings Guidance for the Year 2026The Ensign Group, Inc. provided earnings guidance for the year 2026. For the period, the company expects annual 2026 earnings guidance of $7.41 to $7.61 per diluted share and annual revenue guidance of $5.77 billion to $5.84 billion. The midpoint of this 2026 earnings guidance represents an increase of 14.3% over 2025 results and is 36.5% higher than 2024 results.
お知らせ • Nov 04The Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company expects earnings guidance to between $6.48 to $6.54 per diluted share, up from $6.34 to $6.46 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 18.4% over 2024 results and is 36.5% higher than 2023 results. The company also increasing annual revenue guidance to $5.05 billion to $5.07 billion, up from $4.99 billion to $5.02 billion, to account for current quarter growth and acquisitions have closed and anticipate closing through the remainder of the year.
お知らせ • Jul 25the Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company is raising annual 2025 earnings guidance to between $6.34 to $6.46 per diluted share, up from previously raised guidance of $6.22 to $6.38 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of more than 16% over 2024 results and is 34% higher than 2023 results. The company is also increasing annual revenue guidance to $4.99 billion to $5.02 billion, up from $4.89 billion to $4.94 billion, to account for current quarter performance and acquisitions company anticipate closing through the third quarter.
お知らせ • Apr 30+ 1 more updateThe Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company now expected earnings guidance to between $6.22 to $6.38 per diluted share, up from $6.16 to $6.34 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 14.5% over their 2024 results and is 32.1% higher than their 2023 results. The company also increased annual revenue guidance to $4.89 billion to $4.94 billion, up from $4.83 billion to $4.91 billion, to account for current quarter growth and acquisitions and anticipate closing during the first half of 2025.
お知らせ • Jul 28The Ensign Group, Inc. to Report Q2, 2026 Results on Jul 28, 2026The Ensign Group, Inc. announced that they will report Q2, 2026 results on Jul 28, 2026
Reported Earnings • Jul 27Second quarter 2026 earnings released: EPS: US$1.72 (vs US$1.48 in 2Q 2025)Second quarter 2026 results: EPS: US$1.72 (up from US$1.48 in 2Q 2025). Revenue: US$1.44b (up 17% from 2Q 2025). Net income: US$99.7m (up 18% from 2Q 2025). Profit margin: 6.9% (in line with 2Q 2025). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Healthcare industry in Europe.
お知らせ • Jul 27The Ensign Group, Inc. Raises Earnings Guidance for the Year 2026The Ensign Group, Inc. raised earnings guidance for the year 2026. Due to the strength of the second quarter, the company is increasing its annual 2026 earnings guidance to $7.75 to $7.85 per diluted share, up from the previously increased guidance of $7.48 to $7.62. The company is also increasing annual revenue guidance to $5.87 billion to $5.92 billion, up from $5.81 billion to $5.86 billion. The midpoint of the earnings guidance represents an 18.7% increase over 2025 and 41.8% over 2024.
お知らせ • Jun 29+ 7 more updatesThe Ensign Group, Inc.(NasdaqGS:ENSG) dropped from Russell Small Cap Comp Growth BenchmarkThe Ensign Group, Inc.(NasdaqGS:ENSG) dropped from Russell Small Cap Comp Growth Benchmark
Declared Dividend • Jun 24Dividend of US$0.065 announcedShareholders will receive a dividend of US$0.065. Ex-date: 29th June 2026 Payment date: 31st July 2026 Dividend yield will be 0.1%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 4%. Cash payout ratio: 4%.
お知らせ • Jun 20The Ensign Group, Inc. Declares Quarterly Dividend, Payable on or Before July 31, 2026The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before July 31, 2026, to shareholders of record as of June 30, 2026.
New Risk • Jun 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Jun 10The Ensign Group, Inc. (NasdaqGS:ENSG) announces an Equity Buyback for $40 million worth of its shares.The Ensign Group, Inc. (NasdaqGS:ENSG) announces a share repurchase program. Under the program, the company will repurchase $40 million worth of common stock.
お知らせ • Apr 28The Ensign Group, Inc. to Report Q1, 2026 Results on Apr 30, 2026The Ensign Group, Inc. announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Apr 04The Ensign Group, Inc., Annual General Meeting, May 13, 2026The Ensign Group, Inc., Annual General Meeting, May 13, 2026. Location: ensign services, inc, service center 29222 rancho, suite 127, san juan capistrano, california 92675., United States
お知らせ • Feb 05The Ensign Group, Inc. Provides Earnings Guidance for the Year 2026The Ensign Group, Inc. provided earnings guidance for the year 2026. For the period, the company expects annual 2026 earnings guidance of $7.41 to $7.61 per diluted share and annual revenue guidance of $5.77 billion to $5.84 billion. The midpoint of this 2026 earnings guidance represents an increase of 14.3% over 2025 results and is 36.5% higher than 2024 results.
お知らせ • Feb 03The Ensign Group, Inc. to Report Q4, 2025 Results on Feb 04, 2026The Ensign Group, Inc. announced that they will report Q4, 2025 results on Feb 04, 2026
お知らせ • Dec 19The Ensign Group, Inc. Increases Quarterly Cash Dividend, Payable on or Before January 31, 2026The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0650 per share of Ensign common stock, payable on or before January 31, 2026, to shareholders of record as of December 31, 2025.
お知らせ • Nov 04The Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company expects earnings guidance to between $6.48 to $6.54 per diluted share, up from $6.34 to $6.46 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 18.4% over 2024 results and is 36.5% higher than 2023 results. The company also increasing annual revenue guidance to $5.05 billion to $5.07 billion, up from $4.99 billion to $5.02 billion, to account for current quarter growth and acquisitions have closed and anticipate closing through the remainder of the year.
お知らせ • Oct 21The Ensign Group, Inc. to Report Q3, 2025 Results on Nov 03, 2025The Ensign Group, Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2025
お知らせ • Sep 19The Ensign Group, Inc. Declares A Quarterly Cash Dividend , Payable on or Before October 31, 2025The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0625 per share of Ensign common stock, payable on or before October 31, 2025, to shareholders of record as of September 30, 2025.
お知らせ • Sep 03Ensign Pays over $47 Million to Settle Claims in Whistleblower Suit Alleging Fraud and KickbacksWhistleblower Law Collaborative LLC, Hirst Law Group, P.C., and Bird, Marella, Rhow, Lincenberg, Drooks, & Nessim, LLP announced a settlement of over $47.3 million in a whistleblower case against The Ensign Group, Inc., and Ensign Services, Inc. ("Ensign"). The settled claims, brought in a lawsuit filed by a whistleblower in 2015, resolve allegations that Ensign knowingly engaged in fraud perpetrated against Medicare, Medicaid, and other government health care programs. The complaint, filed as a qui tam suit under the federal and California False Claims Acts (FCAs), alleged that nationwide Ensign knowingly paid kickbacks to physicians for referrals of patients to Ensign's skilled nursing facilities (SNFs) in violations of the FCAs, the federal and California Anti-Kickback Statutes, and the federal Stark self-referral law. The complaint also alleged that Ensign violated a previous Corporate Integrity Agreement (CIA) that Ensign signed with the Department of Health and Human Services (HHS) in 2013 as part of an earlier False Claims Act case settled by the company. The whistleblower worked as a former Contracts Manager at Ensign. In that role, she was responsible for reviewing, tracking, and monitoring contracts entered into by Ensign's Facilities. She also served on the Company's Compliance Committee where one of her responsibilities was to ensure that payment provisions in Ensign's contracts were in accordance with the law. The whistleblower alleged that she complained about the fraud she observed but could not get Ensign to change its conduct. As the second amended complaint alleged, as part of her work, the whistleblower observed, among other fraud, that: Ensign made inflated monthly payments to physicians to serve as medical directors and in other "consulting" capacities, when those excessive payments were designed to induce the doctors to refer patients to the Ensign's SNFs; Ensign SNF administrators admitted that while they used to pay for patient referrals with "donuts," they were now paying for referrals with "dollars"; Another Ensign administrator admitted that he performed a return on investment calculation to determine the number of referrals needed from each doctor to break even on the monthly payments made to those doctors -- and that he would raise or lower the payments to the doctors based on their number of referrals; and Ensign paid thousands of dollars each month for multiple medical directors and consultants. At one SNF alone, Ensign paid four doctors to serve as "medical directors" and paid at least ten additional doctors for "consulting agreements."The whistleblower alleged that she attempted to stop the fraud by changing the contracts to institute hourly rates tied to actual work and fair market value, rather than excessive monthly lump sum payments to induce referrals, but her attempts were overridden by Ensign. Whistleblower Law Collaborative and Hirst Law Group filed the FCAqui tam suit on behalf of the whistleblower, who alleged that Ensign had both engaged in fraud and failed to disclose its illegal conduct to the government as required. When the government allowed the whistleblower to proceed with the FCA suit in 2020, Whistleblower Law Collaborative and Hirst Law Group went forward with the case with Bird Marella as taint counsel. The team proceeded to successfully litigate the case for four years and were in the midst of discovery when the settlement was reached.
お知らせ • Jul 25the Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company is raising annual 2025 earnings guidance to between $6.34 to $6.46 per diluted share, up from previously raised guidance of $6.22 to $6.38 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of more than 16% over 2024 results and is 34% higher than 2023 results. The company is also increasing annual revenue guidance to $4.99 billion to $5.02 billion, up from $4.89 billion to $4.94 billion, to account for current quarter performance and acquisitions company anticipate closing through the third quarter.
お知らせ • Jul 22The Ensign Group, Inc. to Report Q2, 2025 Results on Jul 24, 2025The Ensign Group, Inc. announced that they will report Q2, 2025 results on Jul 24, 2025
お知らせ • Jun 21The Ensign Group, Inc. Announces Board Changes, Effective September 1, 2025The Ensign Group, Inc. announced that Christopher Christensen, Executive Chairman and member of the Ensign Board of Directors, has provided notice to the board of his intent to retire from both his roles effective September 1, 2025. Barry R. Port, Ensign’s Chief Executive Officer, has been appointed to serve as Chair of the Board of Directors, effective September 1, 2025. Mr. Port will continue to serve as Ensign’s Chief Executive Officer, a role he’s held since May 30, 2019. Prior to that, he served as Chief Operating Officer for Ensign Services, Inc. for five years and has been with the organization in various operational roles for over 21 years. Mr. Port has served as Chief Executive Officer since May 2019 and is a currently a member of the board. Before becoming CEO, Mr. Port served as Chief Operating Officer at Ensign Services, Inc. from January 2012 to May 2019, overseeing field support and back-office services for affiliated skilled nursing and senior living operations nationwide. Prior to that, he was President of Keystone Care, Inc. from March 2006 to December 2011, where he provided operational oversight for facilities across Texas. Earlier in his career, he held various roles operating affiliated skilled nursing campuses in Arizona and Texas. In addition, Marivic Uychiat has been appointed to serve as a member of the Board of Directors, filling the vacancy on the board created by Mr. Christensen’s retirement, effective September 1, 2025. Ms. Uychiat has been a key contributor in the organization for over 22 years and has served as Executive Vice President of Clinical Services at Ensign Services, Inc. since 2016. Before assuming her current role, Ms. Uychiat served as Director of Clinical Services for the company’s California operations. Her extensive background also includes a decade-long tenure as Director of Nursing at Vista Knoll Specialized Care, where she oversaw comprehensive care for psychiatric/neuro-behavioral, dementia, and short-term post-acute rehabilitation patients. Ms. Uychiat holds a Bachelor's Degree in nursing, graduating Cum Laude from the University of St. La Salle. She also completed the Chief Nursing Officer program at University of California Irvine Paul Merage School of Business. She brings nearly three decades of leadership in the Skilled Nursing and Post-Acute Care industry to the board.Her professional expertise spans skilled healthcare management, clinical program development, and policymaking.
お知らせ • Jun 20the Ensign Group, Inc. Declares Quarterly Dividend, Payable on or Before July 31, 2025The Ensign Group, Inc. announced that it has declared a quarterly cash dividend of $0.0625 per share of Ensign common stock, payable on or before July 31, 2025, to shareholders of record as of June 30, 2025.
お知らせ • Jun 03The Ensign Group, Inc. (NasdaqGS:ENSG) acquired operations of Ironwood Rehabilitation and Care Center.The Ensign Group, Inc. (NasdaqGS:ENSG) acquired operations of Ironwood Rehabilitation and Care Center on June 1, 2025. The Ensign Group, Inc. (NasdaqGS:ENSG) completed the acquisition of operations of Ironwood Rehabilitation and Care Center on June 1, 2025.
お知らせ • Apr 30+ 1 more updateThe Ensign Group, Inc. Raises Earnings Guidance for the Year 2025The Ensign Group, Inc. raised earnings guidance for the year 2025. For the year, the company now expected earnings guidance to between $6.22 to $6.38 per diluted share, up from $6.16 to $6.34 per diluted share. The new midpoint of this increased 2025 earnings guidance represents an increase of 14.5% over their 2024 results and is 32.1% higher than their 2023 results. The company also increased annual revenue guidance to $4.89 billion to $4.94 billion, up from $4.83 billion to $4.91 billion, to account for current quarter growth and acquisitions and anticipate closing during the first half of 2025.